Hanwha Q Cells Co. Ltd. (NASDAQ:HQCL) has received a consensus broker rating score of 3.00 (Hold) from the one analysts that cover the company, Zacks Investment Research reports. One analyst has rated the stock with a hold rating.
Brokerages have set a one year consensus price target of $13.00 for the company and are expecting that the company will post $0.20 EPS for the current quarter, according to Zacks. Zacks has also assigned Hanwha Q Cells Co. an industry rank of 168 out of 265 based on the ratings given to related companies.
Several equities research analysts recently issued reports on the company. Zacks Investment Research lowered Hanwha Q Cells Co. from a “hold” rating to a “strong sell” rating in a research note on Tuesday, August 9th. Roth Capital lowered Hanwha Q Cells Co. from a “buy” rating to a “neutral” rating in a research note on Friday, August 5th.
A number of large investors have recently modified their holdings of the company. Morgan Stanley raised its stake in shares of Hanwha Q Cells Co. by 12.8% in the third quarter. Morgan Stanley now owns 181,537 shares of the company’s stock valued at $2,035,000 after buying an additional 20,545 shares during the period. KBC Group NV raised its stake in shares of Hanwha Q Cells Co. by 36.3% in the third quarter. KBC Group NV now owns 17,098 shares of the company’s stock valued at $192,000 after buying an additional 4,554 shares during the period. Guggenheim Capital LLC raised its stake in shares of Hanwha Q Cells Co. by 27.8% in the second quarter. Guggenheim Capital LLC now owns 493,596 shares of the company’s stock valued at $7,108,000 after buying an additional 107,408 shares during the period. Walleye Trading LLC raised its stake in shares of Hanwha Q Cells Co. by 1,166.7% in the second quarter. Walleye Trading LLC now owns 7,600 shares of the company’s stock valued at $109,000 after buying an additional 7,000 shares during the period. Finally, AJO LP purchased a new stake in shares of Hanwha Q Cells Co. during the second quarter valued at about $171,000. 1.29% of the stock is owned by hedge funds and other institutional investors.
Shares of Hanwha Q Cells Co. (NASDAQ:HQCL) traded down 3.53% during midday trading on Monday, hitting $9.03. The stock had a trading volume of 12,983 shares. The firm’s 50-day moving average price is $10.63 and its 200-day moving average price is $12.21. Hanwha Q Cells Co. has a 1-year low of $8.68 and a 1-year high of $28.87. The stock has a market cap of $751.13 million, a price-to-earnings ratio of 4.11 and a beta of 2.75.
Hanwha Q Cells Co. (NASDAQ:HQCL) last posted its quarterly earnings data on Tuesday, November 22nd. The company reported $0.50 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.21 by $0.29. The company earned $707.80 million during the quarter, compared to analyst estimates of $653.40 million. Hanwha Q Cells Co. had a return on equity of 42.02% and a net margin of 6.73%. The company’s quarterly revenue was up 65.7% compared to the same quarter last year. Analysts forecast that Hanwha Q Cells Co. will post $1.67 earnings per share for the current year.
Hanwha Q Cells Co. Company Profile
Hanwha Q CELLS Co, Ltd., formerly Hanwha SolarOne Co, Ltd., is a global solar energy company engaged in the manufacturing of solar modules, and the development and management of downstream solar farms. It manufactures a range of photo voltaic (PV) cells and PV modules at its manufacturing facilities in China and Malaysia using manufacturing process technologies, including those developed at its research and development facilities in Germany.